Page last updated: 2024-09-05

tanshinone ii a and agaric acid

tanshinone ii a has been researched along with agaric acid in 2 studies

Compound Research Comparison

Studies
(tanshinone ii a)
Trials
(tanshinone ii a)
Recent Studies (post-2010)
(tanshinone ii a)
Studies
(agaric acid)
Trials
(agaric acid)
Recent Studies (post-2010) (agaric acid)
6104127014

Protein Interaction Comparison

ProteinTaxonomytanshinone ii a (IC50)agaric acid (IC50)
60 kDa heat shock protein, mitochondrialHomo sapiens (human)4
10 kDa heat shock protein, mitochondrialHomo sapiens (human)4
60 kDa chaperonin Escherichia coli6.2
10 kDa chaperonin Escherichia coli6.2

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Abdeen, S; Chapman, E; Chitre, S; Hoang, QQ; Johnson, SM; Park, Y; Ray, AM; Salim, N; Sivinski, J; Stevens, M; Washburn, A1
Chen, J; Gao, K; Huang, F; Tepe, JJ; Wang, R; Wei, GW1

Other Studies

2 other study(ies) available for tanshinone ii a and agaric acid

ArticleYear
HSP60/10 chaperonin systems are inhibited by a variety of approved drugs, natural products, and known bioactive molecules.
    Bioorganic & medicinal chemistry letters, 2019, 05-01, Volume: 29, Issue:9

    Topics: Biological Products; Chaperonin 10; Chaperonin 60; Escherichia coli; Humans; Inhibitory Concentration 50; Protein Folding; Rafoxanide; Salicylanilides; Suramin

2019
Perspectives on SARS-CoV-2 Main Protease Inhibitors.
    Journal of medicinal chemistry, 2021, 12-09, Volume: 64, Issue:23

    Topics: Antiviral Agents; Coronavirus 3C Proteases; Humans; Protease Inhibitors

2021